A pooled analysis of three trials showed a strong trend ( P value .057) towards increased early mortality with nesiritide [ 93 ].
1
—
—
A pooled analysis of three trials showed a strong trend ( P value .057) towards increased early mortality with nesiritide [ 93 ].